466 related articles for article (PubMed ID: 17728215)
41. HYAL1 hyaluronidase in prostate cancer: a tumor promoter and suppressor.
Lokeshwar VB; Cerwinka WH; Isoyama T; Lokeshwar BL
Cancer Res; 2005 Sep; 65(17):7782-9. PubMed ID: 16140946
[TBL] [Abstract][Full Text] [Related]
42. [Overexpression of human tumor metastasis-related gene TMSG-1 suppresses cell proliferation and invasion of a highly metastatic prostate cancer cell line PC-3M-1E8 in vitro].
Su J; You JF; Wang JL; Cui XL; Fang WG; Zheng J
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):404-7. PubMed ID: 19024511
[TBL] [Abstract][Full Text] [Related]
43. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
[TBL] [Abstract][Full Text] [Related]
44. Transcription-targeted gene therapy for androgen-independent prostate cancer.
Martiniello-Wilks R; Tsatralis T; Russell P; Brookes DE; Zandvliet D; Lockett LJ; Both GW; Molloy PL; Russell PJ
Cancer Gene Ther; 2002 May; 9(5):443-52. PubMed ID: 11961667
[TBL] [Abstract][Full Text] [Related]
45. Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases.
Margheri F; D'Alessio S; Serratí S; Pucci M; Annunziato F; Cosmi L; Liotta F; Angeli R; Angelucci A; Gravina GL; Rucci N; Bologna M; Teti A; Monia B; Fibbi G; Del Rosso M
Gene Ther; 2005 Apr; 12(8):702-14. PubMed ID: 15674398
[TBL] [Abstract][Full Text] [Related]
46. Noscapine inhibits human prostate cancer progression and metastasis in a mouse model.
Barken I; Geller J; Rogosnitzky M
Anticancer Res; 2008; 28(6A):3701-4. PubMed ID: 19189652
[TBL] [Abstract][Full Text] [Related]
47. Targeting ECM-integrin interaction with liposome-encapsulated small interfering RNAs inhibits the growth of human prostate cancer in a bone xenograft imaging model.
Bisanz K; Yu J; Edlund M; Spohn B; Hung MC; Chung LW; Hsieh CL
Mol Ther; 2005 Oct; 12(4):634-43. PubMed ID: 16039164
[TBL] [Abstract][Full Text] [Related]
48. Purine-rich element binding protein (PUR) alpha induces endoplasmic reticulum stress response, and cell differentiation pathways in prostate cancer cells.
Inoue T; Maeno A; Talbot C; Zeng Y; Yeater DB; Leman ES; Kulkarni P; Ogawa O; Getzenberg RH
Prostate; 2009 Jun; 69(8):861-73. PubMed ID: 19267365
[TBL] [Abstract][Full Text] [Related]
49. Chromosome 17-mediated dormancy of AT6.1 prostate cancer micrometastases.
Chekmareva MA; Kadkhodaian MM; Hollowell CM; Kim H; Yoshida BA; Luu HH; Stadler WM; Rinker-Schaeffer CW
Cancer Res; 1998 Nov; 58(21):4963-9. PubMed ID: 9810006
[TBL] [Abstract][Full Text] [Related]
50. The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer.
Turley RS; Finger EC; Hempel N; How T; Fields TA; Blobe GC
Cancer Res; 2007 Feb; 67(3):1090-8. PubMed ID: 17283142
[TBL] [Abstract][Full Text] [Related]
51. Expression of LDL-A module of relaxin receptor in prostate cancer cells inhibits tumorigenesis.
Feng S; Agoulnik AI
Int J Oncol; 2011 Dec; 39(6):1559-65. PubMed ID: 21842120
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor.
Zhang Y; Ma Y; Lu HP; Gao JH; Liang CS; Liu CZ; Zou JT; Wang HQ
Chin Med J (Engl); 2008 Nov; 121(22):2284-9. PubMed ID: 19080333
[TBL] [Abstract][Full Text] [Related]
53. Different effect of paclitaxel on primary tumor mass, tumor cell contents, and metastases for four experimental human prostate tumors expressing luciferase.
El Hilali N; Rubio N; Blanco J
Clin Cancer Res; 2005 Feb; 11(3):1253-8. PubMed ID: 15709196
[TBL] [Abstract][Full Text] [Related]
54. Adenovirus-mediated REIC/Dkk-3 gene transfer inhibits tumor growth and metastasis in an orthotopic prostate cancer model.
Edamura K; Nasu Y; Takaishi M; Kobayashi T; Abarzua F; Sakaguchi M; Kashiwakura Y; Ebara S; Saika T; Watanabe M; Huh NH; Kumon H
Cancer Gene Ther; 2007 Sep; 14(9):765-72. PubMed ID: 17599093
[TBL] [Abstract][Full Text] [Related]
55. The human Y chromosome suppresses the tumorigenicity of PC-3, a human prostate cancer cell line, in athymic nude mice.
Vijayakumar S; Garcia D; Hensel CH; Banerjee M; Bracht T; Xiang R; Kagan J; Naylor SL
Genes Chromosomes Cancer; 2005 Dec; 44(4):365-72. PubMed ID: 16080199
[TBL] [Abstract][Full Text] [Related]
56. [The effects of tissue factor/activated factor VII complex on the invasion and metastasis of human ovarian cancer].
Fang J; Wei WN; Xia LH; Song SJ
Zhonghua Xue Ye Xue Za Zhi; 2004 Sep; 25(9):523-7. PubMed ID: 15569528
[TBL] [Abstract][Full Text] [Related]
57. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
Song Y; Shen K; He CX
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
[TBL] [Abstract][Full Text] [Related]
58. Tectorigenin and other phytochemicals extracted from leopard lily Belamcanda chinensis affect new and established targets for therapies in prostate cancer.
Thelen P; Scharf JG; Burfeind P; Hemmerlein B; Wuttke W; Spengler B; Christoffel V; Ringert RH; Seidlová-Wuttke D
Carcinogenesis; 2005 Aug; 26(8):1360-7. PubMed ID: 15845653
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of tumor cell migration and metastasis by the proton-sensing GPR4 receptor.
Castellone RD; Leffler NR; Dong L; Yang LV
Cancer Lett; 2011 Dec; 312(2):197-208. PubMed ID: 21917373
[TBL] [Abstract][Full Text] [Related]
60. In vivo expression and antitumor activity of p53 gene transfer with naked plasmid DNA in an ovarian cancer xenograft model in nude mice.
Collinet P; Vereecque R; Sabban F; Vinatier D; Leblanc E; Narducci F; Querleu D; Quesnel B
J Obstet Gynaecol Res; 2006 Oct; 32(5):449-53. PubMed ID: 16984510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
